Albert Einstein College of Medicine of Yeshiva University has been awarded a grant of more than $9.25 million from the National Institutes of Health to further the medical school’s study of centenarians and the biology of aging.
Albert Einstein College of Medicine of Yeshiva University announced today that it has been awarded a $10 million grant from the National Heart, Lung and Blood Institute (NHLBI) for a landmark and unprecedented large-scale study of the health status of 4,000 people of Hispanic/Latino origin in the Bronx.
A third of the world’s people are infected with tuberculosis, and someone new is infected every second. TB is notoriously hard to treat, requiring a course of multiple antibiotics over six to nine months. Many people don’t complete the full course of treatment, which leads to increasing antibiotic resistance against the disease.
“I had no idea I could make a living reading books I love,” said Anthony Wexler, a YC senior who was awarded a full scholarship to the English graduate program at The Johns Hopkins University.
Dr. David Fidock, assistant professor of microbiology and immunology at the Albert Einstein College of Medicine, is one of just eight scientists nationally to receive a 2003 Investigator in Pathogenesis Disease Award from the Burroughs Wellcome Fund. The grant, which includes $400,000 in funding over the next five years, supports and encourages aggressive, multidisciplinary approaches to investigating pathogenesis (disease development). The recipients of the award are scientists who are working on understanding the interaction between the human host and infectious agents that may be bacterial, viral, fungal, or parasitic in nature.